On Tuesday, December 20th, Santiago Horgan, MD, chief of minimally invasive surgery at UC San Diego Health System was the first surgeon in the United States to remove a diseased gallbladder through a patient’s belly button with the aid of a new FDA-approved da Vinci Si Surgical System.
In eukaryotes – the group of organisms that include humans – a key to survival is the ability of certain proteins to quickly and accurately repair genetic errors that occur when DNA is replicated to make new cells.
An international team of scientists, led by researchers at the University of California, San Diego School of Medicine, reports that abnormal sequences of DNA known as rare copy number variants, or CNVs, appear to play a significant role in the risk for early onset bipolar disorder.
In an example of life imitating art, biologists and bioengineers at UC San Diego have created a living neon sign composed of millions of bacterial cells that periodically fluoresce in unison like blinking light bulbs.
Solidifying UC San Diego’s role as a research powerhouse with an entrepreneurial culture and collaborative environment, the Triton Greenovation Network (TGN) Challenge concluded its inaugural competition after announcing that students from the Rady School placed first and third in its competition to find the most commercially viable projects with a positive environmental impact.
The Joint Commission (TJC) has approved UC San Diego Health System’s Disease-Specific Care (DSC) Certification for Ventricular Assist Device (VAD). Hospitals performing VAD as a “destination therapy” (for permanent use) receive a certification of distinction and receive reimbursement from Centers for Medicare and Medicaid Services (CMS).
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
